Renaissance Technologies’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-244,981
Closed -$9.71M 4086
2024
Q1
$9.71M Buy
244,981
+28,296
+13% +$1.12M 0.02% 1002
2023
Q4
$4.13M Sell
216,685
-71,509
-25% -$1.36M 0.01% 1474
2023
Q3
$3.3M Sell
288,194
-31,100
-10% -$356K 0.01% 1543
2023
Q2
$3.28M Sell
319,294
-11,000
-3% -$113K ﹤0.01% 1672
2023
Q1
$2.55M Sell
330,294
-2,600
-0.8% -$20.1K ﹤0.01% 1874
2022
Q4
$2.45M Sell
332,894
-25,800
-7% -$190K ﹤0.01% 1952
2022
Q3
$2.58M Sell
358,694
-38,700
-10% -$279K ﹤0.01% 1860
2022
Q2
$3.38M Buy
397,394
+11,300
+3% +$96.2K ﹤0.01% 1837
2022
Q1
$3.46M Sell
386,094
-200
-0.1% -$1.79K ﹤0.01% 1832
2021
Q4
$5.35M Sell
386,294
-9,300
-2% -$129K 0.01% 1489
2021
Q3
$4.22M Sell
395,594
-3,400
-0.9% -$36.3K 0.01% 1570
2021
Q2
$3.59M Buy
398,994
+2,100
+0.5% +$18.9K ﹤0.01% 1845
2021
Q1
$4.21M Sell
396,894
-61,900
-13% -$656K 0.01% 1756
2020
Q4
$5.78M Buy
458,794
+70,111
+18% +$883K 0.01% 1496
2020
Q3
$3.42M Buy
388,683
+164,028
+73% +$1.44M ﹤0.01% 1797
2020
Q2
$2.18M Buy
224,655
+91,500
+69% +$888K ﹤0.01% 2144
2020
Q1
$383K Buy
133,155
+5,345
+4% +$15.4K ﹤0.01% 2884
2019
Q4
$491K Buy
127,810
+15,449
+14% +$59.3K ﹤0.01% 2910
2019
Q3
$445K Buy
112,361
+6,100
+6% +$24.2K ﹤0.01% 2909
2019
Q2
$447K Buy
106,261
+10,400
+11% +$43.7K ﹤0.01% 3038
2019
Q1
$658K Buy
95,861
+8,569
+10% +$58.8K ﹤0.01% 2840
2018
Q4
$321K Sell
87,292
-26,982
-24% -$99.2K ﹤0.01% 3006
2018
Q3
$723K Sell
114,274
-8,150
-7% -$51.6K ﹤0.01% 2740
2018
Q2
$927K Buy
122,424
+21,124
+21% +$160K ﹤0.01% 2631
2018
Q1
$810K Buy
101,300
+33,800
+50% +$270K ﹤0.01% 2735
2017
Q4
$756K Buy
67,500
+15,521
+30% +$174K ﹤0.01% 2769
2017
Q3
$603K Buy
51,979
+48,329
+1,324% +$561K ﹤0.01% 2739
2017
Q2
$35K Buy
+3,650
New +$35K ﹤0.01% 3142